YIYuya Ito

Yuya Ito

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuya Ito has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Hiroshi Takayama

    Department of Internal Medicine Takashima Municipal Hospital Takashima City Shiga Japan

    1 shared publication
  • Makiko Kasahara

    Department of Obstetrics and Gynecology Shiga University of Medical Science Otsu City Shiga Japan

    1 shared publication
  • Shinsuke Tokoro

    Department of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu-City, Shiga Prefecture, Japan

    1 shared publication
  • Shunichiro Tsuji

    Department of Obstetrics and Gynecology, Shiga University of Medical Science, Shiga, Japan

    1 shared publication
  • Takashi Murakami

    Department of Obstetrics and Gynecology Shiga University of Medical Science Otsu City Shiga Japan

    1 shared publication

Latest Publications

  • Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII: A case report and literature review

    by Yuya Ito, Shunichiro Tsuji, Makiko Kasahara, Shinsuke Tokoro, Takashi Murakami, Hiroshi Takayama

    Factor XIII deficiency is an extremely rare autosomal recessive genetic disorder, occurring in 1 of 3–5 million people, and is associated with perinatal complications, such as habitual abortion and prolonged bleeding. Although plasma‐derived factor XIII (Fibrogamin®) carries a risk of infection and contains very low concentrated forms of factor XIII (FXIII) used for a pregnant woman with congenital coagulation factor XIII deficiency, recombinant factor XIII (rFXIII, Novo Thirteen®; Tretten®, Novo Nordisk, Bagsværd, Denmark), which has no risk of infection and is highly concentrated, has emerged as a novel formulation. Herein, we report the first case of a Japanese pregnant woman with congenital coagulation factor XIII deficiency successfully managed by rFXIII. She had a good perinatal course without pregnancy‐related complications and transfusion through the perinatal period.